Evaluating the place of low-molecular-weight heparin in the management of acute coronary syndromes. A panel discussion with audience participation

Clin Cardiol. 2001 Mar;24(3 Suppl):I20-2. doi: 10.1002/clc.4960241307.
No abstract available

MeSH terms

  • Angina, Unstable / drug therapy*
  • Anticoagulants / therapeutic use*
  • Atrial Fibrillation / complications
  • Dalteparin / therapeutic use*
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Myocardial Infarction / drug therapy*
  • Thrombolytic Therapy*

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight
  • Dalteparin